Pharmafile Logo
Pharmafocus logo
Advanced Search
depressed_4649749639

COVID-19 increases the risk of developing psychiatric disorders, new study says

November 12, 2020
Business Services

People who are infected with COVID-19 are at higher risk of developing depression, insomnia and anxiety for the first time, …

News
flu_vaccination_grippe_5115654021

Pfizer/BioNTech vaccine side effects feel like a “severe hangover”

November 12, 2020
Business Services COVID, Vaccine, coronavirus

Clinical trial participants receiving the Pfizer/BioNTech coronavirus vaccine have said it created side effects that felt similar to a “severe …

News
reuters_-_tatyana_makeyeva

First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine

November 11, 2020
Research and Development COVID-19, Russia, Sputnik V, Vaccine

The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …

News
1200px-vaccine_image_1

Head of UK vaccine taskforce grilled over government investment into her private equity firm

November 11, 2020
Research and Development COVID, UK COVID, coronavirus

Kate Bingham, the Head of the British Government’s vaccine taskforce, is facing further questions over a conflict of interest as …

News
512px-curevac_in_tubingen_02

CureVac’s COVID-19 vaccine generates immune responses at Phase 1

November 11, 2020
Research and Development COVID-19, CureVac, pharma

German biopharma firm CureVac has unveiled interim analysis data from a Phase1 study of its messenger RNA (mRNA) COVID-19 vaccine, CVnCoV, …

News
gym_wiki

Hotels, gyms and restaurants carry highest COVID-19 spread risk, new study says

November 11, 2020
Research and Development COVID, coronavirus

Reopening hotels, gyms and restaurants carries the highest risk of spreading coronavirus, according to a new study. 

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 11, 2020
Research and Development

The COVID-19 news this week focuses on vaccines, with AstraZeneca committing to an agreement to deliver 22 million doses of …

News
vaccination-1215279_960_720

Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis

November 10, 2020
Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …

News
nice_reception_2

NICE recommends venetoclax combo, a non-chemo option for untreated chronic lymphocytic leukaemia

November 10, 2020
Manufacturing and Production, Sales and Marketing AbbVie, NHS, NICE, UK, leukaemia, venetoclax

NICE has recommended venetoclax in combination with obinutuzumab under final draft guidance for the first-line treatment of untreated chronic lymphocytic …

News
stethoscope_and_background_doctor

Scottish Medicines Consortium greenlights Nubeqa for prostate cancer

November 10, 2020
Manufacturing and Production, Sales and Marketing

The Scottish Medicines Consortium has approved Nubeqa for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC) who are …

News
unnamed_1

FDA grants Emergency Use Authorization to Eli Lilly’s antibody drug to treat COVID-19

November 10, 2020
Manufacturing and Production

The FDA has granted Emergency Use Authorization (EUA) to Eli Lilly’s antibody drug bamlanivimab for the treatment of COVID-19 patients …

News
flu_vaccination_grippe_5115654021

Sinovac COVID-19 trial suspended in Brazil due to severe adverse event

November 10, 2020
Manufacturing and Production Brazil, COVID, COVID Vaccine, coronavirus

Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a …

News
astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020
Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …

News
shutter

AstraZeneca’s Brilinta combo reduces rate of disabling stroke or death in stroke patients, according to Phase 3 data

November 9, 2020
Research and Development, Sales and Marketing AstraZeneca, Brilinta, pharma

AstraZeneca has unveiled new Phase 3 data for Brilinta (ticagrelor) as a treatment for patients who have suffered an acute …

News
1200px-vaccine_image_1

Head of UK’s COVID-19 vaccine taskforce faces questions over biotech fund

November 9, 2020
Sales and Marketing COVID, COVID-19, vaccines

Kate Bingham, the head of the British Government’s vaccine taskforce, faces scrutiny after it was revealed her venture capital firm …

News
fda_white_oak_building_web_0

FDA approves Nightware app on Apple Watch to treat sleep disturbances

November 9, 2020
Sales and Marketing

The FDA has authorised the marketing of Nightware, a digital therapeutic application for the Apple Watch, in treating sleep disturbances.  …

News
hiv_on_macrophage

Viiv Healthcare’s cabotegravir effective in HIV prevention in women

November 9, 2020
Sales and Marketing AIDS, HIV

Viiv Healthcare’s cabotegravir is more effective in preventing HIV in women than the oral standard of care, according to an …

News

China approves Astellas’ Xtandi in non-metastatic castration-resistant prostate cancer

November 6, 2020
Medical Communications, Sales and Marketing Astellas, China, NMPA, Xtandi

China’s drug regulator, the National Medical Products Administration (NMPA), has given the green light to Astellas to market Xtandi (enzalutamide …

News
jnjioffice

Johnson & Johnson and three drug distributors close to $26 billion settlement

November 6, 2020
Medical Communications

Johnson & Johnson, McKesson, Cardinal Health and AmerisourceBergen are close to a $26 billion deal with local and state governments …

News
china_red_flag

US Department of Justice looking into Pfizer’s operations in China

November 6, 2020
Medical Communications

The US Department of Justice and the US Securities and Exchange Commission (SEC) are investigating Pfizer’s operations in China after …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026